We are live on ! Find out more
GCTK icon

GlucoTrack

4 hedge funds and large institutions have $69.8K invested in GlucoTrack in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.06% more ownership

Funds ownership: 0%0.06% (+0.06%)

32% less capital invested

Capital invested by funds: $103K → $69.8K (-$32.8K)

50% less funds holding

Funds holding: 84 (-4)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
4
Holders Change
-4
Holders Change %
-50%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
Closed
6
Calls
Puts
Net Calls
Net Calls Change

GCTK Hedge Fund Activity: Q1 2025 in Review

4 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q1 2025, worth a combined $69.8K — down 32% from $103K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of GCTK and 2 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Alerus Financial, adding an estimated $335K. The largest seller was Geode Capital Management, exiting entirely with an estimated $42.1K sold.

  • 4 institutional investors held GlucoTrack (GCTK) as of Q1 2025, down from 8 in Q4 2024.
  • Funds reported $69.8K of GlucoTrack stock for Q1 2025, down 32% quarter-over-quarter.
  • 2 funds opened new GlucoTrack positions in Q1 2025 and 6 closed out, a net change of -4 holders.
  • The largest GlucoTrack buyer in Q1 2025 was Alerus Financial, an estimated $335K added.
  • The largest GlucoTrack seller in Q1 2025 was Geode Capital Management, an estimated $42.1K sold.

Based on aggregated 13F filings for Q1 2025.